Contrave vs Foundayo
Side-by-side comparison of Contrave (naltrexone HCl + bupropion HCl ER) and Foundayo (orforglipron) across efficacy, food restrictions, monthly cost, and Medicare Bridge coverage.
Foundayo
Based on the data below, Foundayo wins on covered under the Medicare GLP-1 Bridge ($50/mo from Jul 1, 2026). Your situation may differ — try the personalized matcher on the homepage or compute your real out-of-pocket with the cost calculator on each medication's detail page.
Contrave
naltrexone HCl + bupropion HCl ER · Nalpropion Pharmaceuticals (Currax Pharmaceuticals)
| Field | Contrave | Foundayo |
|---|---|---|
| Route | tablet · daily | tablet · daily |
| Avg weight loss | 5–9% | 12–16% |
| Food restriction | Avoid high-fat meals | No food OR water |
| Cash from | $650/mo | $149/mo |
| Savings card | — | $25/mo |
| Medicare Bridge | Tier 3 | $50/mo ✓ |
| A1c reduction | — | — |
| FDA approved | 2014-09 | 2026-04 |
- RouteContravetablet · dailyFoundayotablet · daily
- Avg weight lossContrave5–9%Foundayo12–16%
- Food restrictionContraveAvoid high-fat mealsFoundayoNo food OR water
- Cash fromContrave$650/moFoundayo$149/mo
- Savings cardContrave—Foundayo$25/mo
- Medicare BridgeContraveTier 3Foundayo$50/mo ✓
- A1c reductionContrave—Foundayo—
- FDA approvedContrave2014-09Foundayo2026-04
Pick Contrave if…
Pick Foundayo if…
- You can't reliably do a fasting window before meds
- You're on Medicare and want the $50/mo Bridge price
- Cash pay matters more than peak weight loss ($149/mo cheaper)
- You want the higher peak efficacy (16% vs 9%)
Not sure which fits?
The 30-second matcher on the homepage scores every 2026 GLP-1 against your goals + preferences and recommends the best fit.